153 related articles for article (PubMed ID: 7537711)
21. Expression of CD44 in prostate cancer cells: association with cell proliferation and invasive potential.
Lokeshwar BL; Lokeshwar VB; Block NL
Anticancer Res; 1995; 15(4):1191-8. PubMed ID: 7544562
[TBL] [Abstract][Full Text] [Related]
22. Expression of cytokeratin 19 in human hepatocellular carcinoma cell lines.
Wu F; Nishioka M; Fujita J; Murota M; Ohtsuki Y; Ishida T; Kuriyama S
Int J Oncol; 2002 Jan; 20(1):31-7. PubMed ID: 11743639
[TBL] [Abstract][Full Text] [Related]
23. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
[TBL] [Abstract][Full Text] [Related]
24. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro].
Zhang Y; Hu MY; Chen BH; Wang ZJ; Zha XL; Liu KD
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):530-5. PubMed ID: 16681881
[TBL] [Abstract][Full Text] [Related]
25. Functional hyaluronan receptors are expressed on a squamous cell lung carcinoma cell line but not on other lung carcinoma cell lines.
Teder P; Bergh J; Heldin P
Cancer Res; 1995 Sep; 55(17):3908-14. PubMed ID: 7543820
[TBL] [Abstract][Full Text] [Related]
26. Expression patterns of CD44 adhesion molecule in testicular germ cell tumors and normal testes.
Miyake H; Hara I; Yamanaka K; Gohji K; Arakawa S; Kamidono S
Am J Pathol; 1998 May; 152(5):1157-60. PubMed ID: 9588883
[TBL] [Abstract][Full Text] [Related]
27. Receptor activator of nuclear factor-kappaB ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis.
Sasaki A; Ishikawa K; Haraguchi N; Inoue H; Ishio T; Shibata K; Ohta M; Kitano S; Mori M
Ann Surg Oncol; 2007 Mar; 14(3):1191-9. PubMed ID: 17195907
[TBL] [Abstract][Full Text] [Related]
28. Aberrant splicing of Hugl-1 is associated with hepatocellular carcinoma progression.
Lu X; Feng X; Man X; Yang G; Tang L; Du D; Zhang F; Yuan H; Huang Q; Zhang Z; Liu Y; Strand D; Chen Z
Clin Cancer Res; 2009 May; 15(10):3287-96. PubMed ID: 19447873
[TBL] [Abstract][Full Text] [Related]
29. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis.
Tian J; Tang ZY; Ye SL; Liu YK; Lin ZY; Chen J; Xue Q
Br J Cancer; 1999 Nov; 81(5):814-21. PubMed ID: 10555751
[TBL] [Abstract][Full Text] [Related]
30. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines.
Hofmann M; Rudy W; Zöller M; Tölg C; Ponta H; Herrlich P; Günthert U
Cancer Res; 1991 Oct; 51(19):5292-7. PubMed ID: 1717145
[TBL] [Abstract][Full Text] [Related]
31. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
32. Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H.
Cannistra SA; Kansas GS; Niloff J; DeFranzo B; Kim Y; Ottensmeier C
Cancer Res; 1993 Aug; 53(16):3830-8. PubMed ID: 8339295
[TBL] [Abstract][Full Text] [Related]
33. Functional heterogeneity of CD44 molecules in ovarian cancer cell lines.
Cannistra SA; DeFranzo B; Niloff J; Ottensmeir C
Clin Cancer Res; 1995 Mar; 1(3):333-42. PubMed ID: 9815989
[TBL] [Abstract][Full Text] [Related]
34. Expression of CD44 and variant isoforms in cultured human retinal pigment epithelial cells.
Liu NP; Roberts WL; Hale LP; Levesque MC; Patel DD; Lu CL; Jaffe GJ
Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2027-37. PubMed ID: 9331266
[TBL] [Abstract][Full Text] [Related]
35. [Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2].
Xu JY; Chen LB; Xu JY; Yang Z; Wei HY; Xu RH
Ai Zheng; 2006 May; 25(5):526-32. PubMed ID: 16687068
[TBL] [Abstract][Full Text] [Related]
36. Participation of liver cancer stem/progenitor cells in tumorigenesis of scirrhous hepatocellular carcinoma--human and cell culture study.
Fujii T; Zen Y; Harada K; Niwa H; Masuda S; Kaizaki Y; Watanabe K; Kawashima A; Nakanuma Y
Hum Pathol; 2008 Aug; 39(8):1185-96. PubMed ID: 18547618
[TBL] [Abstract][Full Text] [Related]
37. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
[TBL] [Abstract][Full Text] [Related]
38. Detection of a unique gamma-glutamyl transpeptidase messenger RNA species closely related to the development of hepatocellular carcinoma in humans: a new candidate for early diagnosis of hepatocellular carcinoma.
Tsutsumi M; Sakamuro D; Takada A; Zang SC; Furukawa T; Taniguchi N
Hepatology; 1996 May; 23(5):1093-7. PubMed ID: 8621139
[TBL] [Abstract][Full Text] [Related]
39. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.
Tong AW; Papayoti MH; Netto G; Armstrong DT; Ordonez G; Lawson JM; Stone MJ
Clin Cancer Res; 2001 Mar; 7(3):691-703. PubMed ID: 11297266
[TBL] [Abstract][Full Text] [Related]
40. [Expression of liver-type fatty acid-binding protein and vascular endothelial growth factor and their correlation in human hepatocellular carcinoma].
Dong LH; Li H; Wang F; Li FQ; Zhou HY; Yang HJ
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):318-21. PubMed ID: 17425983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
